Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/17/26 18:27 | 7/15/26 | NUVB | Health | Drug | Pharmaceutical Preparations | Sauvage Philippe | NY | O | CFO | 3 | M.d | 477 | 3.52 | 0 | 135 | 54 | D | |||||||||||||||
6/24/26 19:09 | 6/23/26 | NUVB | Health | Drug | Pharmaceutical Preparations | Markel Stacy | NY | O | Chief Pe | 2 | M.d | 982 | 3.93 | 0 | 250 | 33 | D | |||||||||||||||
6/24/26 19:09 | 6/23/26 | NUVB | Health | Drug | Pharmaceutical Preparations | Markel Stacy | NY | O | Chief Pe | 2 | S.d | -982 | 3.93 | 0 | -250 | 33 | D | |||||||||||||||
6/24/26 19:07 | 6/23/26 | NUVB | Health | Drug | Pharmaceutical Preparations | Wentworth Kerry | NY | O | Chief Re | 2 | M.d | 564 | 4.47 | 0 | 126 | 53 | D | |||||||||||||||
6/24/26 19:07 | 6/23/26 | NUVB | Health | Drug | Pharmaceutical Preparations | Wentworth Kerry | NY | O | Chief Re | 2 | S.d | -564 | 4.47 | 0 | -126 | 53 | D | |||||||||||||||
6/11/26 20:02 | 6/9/26 | NUVB | Health | Drug | Pharmaceutical Preparations | Mashal Robert | NY | D | 1 | P | 118 | 4.73 | 0 | 25 | 13 | 225 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |